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Following coronary artery surgery, most patients undergo intermittent positive pressure ventilation (IPPV) electively for a period. Correct assessment of pain and distress in such patients is based on appearance and cardiovascular changes such as hypertension and tachycardia. However, despite apparently adequate analgesia, after coronary artery surgery a large proportion of patients develop hypertension which requires vasodilator therapy such as an i.v. infusion of sodium nitroprusside (SNP) [1] .
The ease of control of hypertension using vasodilators may be a useful method of assessing the adequacy of sedation and analgesia. Measurement of this is possible using a computercontrolled closed loop system such as that developed by Reid and Kenny [2] , which controls arterial hypertension with an infusion of SNP.
An appropriate method of providing adequate analgesia and sedation to prevent inappropriate swings of arterial pressure following stimuli such as tracheal suction or changing position may be an infusion of alfentanil, an opioid with rapid onset and short duration of action. This would allow adequate analgesia when appropriate, and permit rapid recovery after the infusion was discontinued. Yate and colleagues [3] [4] [5] The aim of our study was to assess the sedative and analgesic properties of alfentanil, and its effects on cardiovascular stability. Morphine was used as a control.
PATIENTS AND METHODS
The study was approved by the hospital Ethics Committee and informed consent was obtained from each patient. Forty patients who had undergone coronary artery bypass surgery and required postoperative vasodilator therapy were assigned randomly to receive either alfentanil or morphine infusions after operation. All patients had ECG monitoring, direct arterial pressure monitored from the radial artery and central venous pressure recorded via a right internal jugular cannula, both in theatre and in the postoperative period in the ICU. The computercontrolled closed loop system was used to administer SNP via a second dedicated central venous cannula. The cardiac surgical staff recommended the target arterial systolic pressure to which the closed loop system was set. Thereafter, the closed loop control system maintained arterial pressure as close to this as possible by varying the rate of infusion of SNP. Heart rate, arterial pressures (systolic, diastolic and mean), SNP infusion rate and target pressure were recorded on the data disc every 1 min. This closed loop control system has been described elsewhere in greater detail [2] .
Following transfer of the patient to the intensive care unit, the standard practice of omitting analgesia or sedation until neurological assessment was continued. When the patient had recovered sufficiently to move all four limbs to command, a bolus dose of midazolam 2 mg was administered. The alfentanil group received a bolus of alfentanil 1 mg and an alfentanil infusion was commenced at a rate of 0.5 ug kg" 1 min"
1
. The morphine group received a bolus of morphine 2 mg (3 mg if the patient's weight was more than 75 kg), and an infusion of morphine 2mgh" 1 . Infusion rates were adjusted by the nursing staff to a maximum of alfentanil 2.0 ug kg" 1 min" 1 or morphine 6 mg h" 1 . Additional bolus doses of alfentanil 0.5 mg or morphine 1 mg were given if further analgesia was required. Midazolam 2 mg was given if staff considered that the patient was excessively aware. A record was made of the infusion rates, and of any additional bolus doses of opioid or hypnotic agent.
A simple six-point scoring chart (table I) every 30 min for 3 h and thereafter every 1 h until infusions were discontinued. Sedation scores of 3 and 4 were considered optimal.
Once the patient was normothermic (core temperature > 36.5 °C), haemodynamically stable and with acceptable arterial blood-gas tensions, the opioid infusions were discontinued. When the patient had recovered sufficiently, s/he was allowed to breathe spontaneously via a T-piece. If arterial blood-gas tensions were satisfactory and the patient sufficiently awake, extubation was performed. Times from stopping the infusion to recovery of spontaneous ventilation and extubation of the trachea were recorded. If any further analgesia were required, papaveretum was administered i.m.
Later analysis of the arterial pressures recorded on the data disc allowed calculation of the time spent by each patient outside the target pressure ±5, 10, 15 and 20 mm Hg. The average SNP infusion rate was also calculated.
Data from the two groups were compared using the Mann-Whitney U test. Statistical significance was deemed present if P < 0.05.
RESULTS
There was no difference between the two groups in age, sex distribution, weight or time spent on cardiopulmonary bypass. Anaesthetic regimens were not standardized, but differences between the agents used in each of the groups were not significant (table II) .
There were no differences in the duration of opioid infusions or in the number of alterations in infusion rate (table III) . However, the alfentanil group required significantly less additional bolus doses of opioid. In addition, less midazolam was required in the alfentanil group, although this did not achieve statistical significance.
One patient in the alfentanil group did not require arterial pressure control once the opioid infusion was commenced. Of the remaining patients, when under computer control those in the alfentanil group had arterial pressures either above the target value plus 5, 10, 15 and 20 mm Hg ( fig. 1, table IV) or below the target value minus 5, 10, 15 and 20 mm Hg ( fig. 2, table IV) for significantly shorter periods than those in the morphine group. In addition, the average hourly infusion rate of SNP was significantly less in the alfentanil group. Quality of sedation while the patients received opioid infusions is shown in figure 3 . Although the group receiving alfentanil appeared to spend a greater percentage of time more heavily sedated (categories 1-3), there were no statistically significant differences between the two groups at each level of sedation.
The time to recovery of spontaneous ventilation and to extubation of the trachea is shown in table V. No differences were noted between the groups.
DISCUSSION
The provision of appropriate sedation in an intensive care unit has always been difficult. The ideal agent would produce sedation and analgesia with no adverse cardiovascular effects and have a short elimination half-life with predictable but minimal accumulation when given by repeated doses or continuous infusion [6] . No single drug provides all of these properties, although propofol may approach the ideal [7] . It is common policy for an opioid infusion to be given with bolus administration of a benzodiazepine [8] , combining continuous analgesia with a variable degree of sedation. Morphine remains the mainstay of intensive care analgesia, although its effects (or the effects of its active metabolites) may be prolonged in patients with renal impairment [9] . Alfentanil has been studied recently as being more appropriate, with its shorter half-life and its lack of cardiovascular effects [10] . As its use is commonly associated with respiratory depression, alfentanil may be of most value for patients whose ventilation is controlled [11, 12] . It is common policy to provide elective IPPV for patients who have undergone cardiopulmonary bypass. These patients differ from those in general intensive care units in that they are generally more fit (with the exception of cardiac pathology) and rarely have significant renal or hepatic disease, hence drug elimination is less of a problem. For these reasons, studies of sedation are often undertaken in this group [4, 5, 7] . Agents that cause excessive or prolonged sedation should be avoided if possible, because these patients are usually transferred from the ICU the day after operation. Following coronary artery surgery, it is particularly important to treat hypertension, a complication which occurs in approximately 30% of patients, and which can lead to increased haemorrhage and myocardial oxygen demand [13] . This trial was directed specifically to the group of patients who required antihypertensive therapy.
The trial was designed with two objectives. The first was to examine the effect of two sedation techniques on cardiovascular responses. Even in the best managed intensive care unit there are episodes of relatively inadequate sedation, particularly during positioning for radiography or when performing tracheal suction. This may be reflected by a period of hypertension. Under such circumstances, the closed loop control system compensates by increasing the rate of infusion. However, for a short period arterial pressure increases from the target pressure. As the closed loop control system records arterial pressure every 1 min, the time spent in various pressure bands can be calculated, hence quantifying the duration and severity of hypertensive episodes. Use of the system demonstrated a significant difference in cardiovascular stability between the two sedation groups, suggesting that the arterial pressure of the patients who received alfentanil did not deviate from the target value as much as those receiving morphine. This could be explained by the improved attenuation of hypertensive responses to noxious or other stimuli in the alfentanil group.
The second objective of the study was to assess the sedative and analgesic action of our dose regimen of alfentanil. While there was no significant difference between the percentage times spent by the two groups at each level of sedation, patients who received alfentanil spent a greater proportion of the time at levels 1-3 and those in the morphine group spent more time at levels 4-6. Our simple scoring system suggests that the patients in the alfentanil group tended to be more sedated than those receiving morphine. This would agree with the ease of control of arterial pressure in this group.
The increased degree of sedation in the alfentanil group would be a disadvantage if this had led to prolonged recovery times. However, we did not demonstrate any difference in rate of recovery in comparison with morphine. A very large range of recovery times in both groups is evident, and demonstrates the difficulties in making predictions on recovery from drugs with a short halflife, such as alfentanil. Prolonged recovery after alfentanil infusions has been reported by other authors [4, 14] .
Patients in the morphine group required a significantly greater number of additional bolus injections. This suggests it is more difficult to control a morphine infusion to achieve a desired degree of sedation, and may be explained by the slower onset time of morphine. The short duration of action of alfentanil requires its administration by continuous infusion. However, its rapid action allowed easier control of the degree of sedation because it required less additional bolus injection. Our choice of alfentanil infusion rate was based on both previous literature [4] and our own clinical observation. Our choice of morphine infusion rate was based on what was common practice in the intensive care unit. The doses of the two opioids administered to patients in our study were similar when calculated on an mg h" 1 basis. However, animal studies have shown that alfentanil is approximately 70 times as potent as morphine [15] , which would result in a much greater attenuation of haemodynamic responses, with improved cardiovascular stability, in the alfentanil group.
